title: Evaluation of central corneal and central retinal thicknesses and intraocular pressure in acromegaly patients.
abstract: BACKGROUND
  Acromegaly is a disorder with increased morbidity which can involve many organs and the eye can be one of them which was investigated in few reports. Herein, we aimed to evaluate CCT, IOP and retinal thickness (RT), and their relationships with serum GH and IGF-1 levels and disease duration, in acromegaly patients. We compared the ocular parameters with those of a control group. This study included the largest number of patients of any comparable investigation to date.
  
  
  METHODS
  We enrolled 30 acromegaly patients (15 male, 15 female and age: 48.4 ± 12.8 years) and 21 age and gender matched controls. All participants underwent complete hormonal and ophtalmological evaluation including central corneal thickness (CCT), retinal thickness (RT) and intraocular pressure (IOP) values.
  
  
  RESULTS
  There were no significant differences in median right and left CCTs and mean CCT (p = 0.646, p = 0.667 and p = 0.384, respectively). Nor were there statistically significant differences in median right and left RT, or mean central RT, between the acromegaly and control groups (p = 0.977, p = 0.738 and p = 0.811, respectively). However median right, left and mean IOPs were found to be significantly higher in the acromegaly group, despite there being no difference in the CCT values (p = 0.011, p = 0.028 and p = 0.047, respectively). When we analyzed two subgroups of acromegaly patients (active/inactive), we found that the median right, left and mean CCTs and RTs, were not significantly different between the groups. Although there was a significant difference in IOP between the acromegaly and control groups, the two subgroups of acromegaly patients had similar IOPs (p = 0.400, p = 0.621 and p = 0.451 for right, left and mean IOPs, respectively). IOP was not found to be correlated with serum IGF-I, GH or disease duration in acromegaly patients.
  
  
  CONCLUSIONS
  Our study results suggest that acromegaly is associated with increased ocular pressures irrespective of disease activity. Therefore detailed ocular evaluation should be a routine component of the follow up visits of acromegaly patients.
authors.affiliation: Endocrinology and Metabolism Department, Ataturk Training and Research Hospital, 6800, Ankara, Turkey, burcakugurlu@gmail.com.
authors.forename: Sefika Burcak
authors.initials: SB
authors.lastname: Polat
authors.forename: Nagihan
authors.initials: N
authors.lastname: Ugurlu
authors.forename: Reyhan
authors.initials: R
authors.lastname: Ersoy
authors.forename: Oguzhan
authors.initials: O
authors.lastname: Oguz
authors.forename: Necati
authors.initials: N
authors.lastname: Duru
authors.forename: Bekir
authors.initials: B
authors.lastname: Cakir
mesh_terms: D000172:Acromegaly / Q000473:pathology* / Q000503:physiopathology*; D000328:Adult; D000368:Aged; D003315:Cornea / Q000473:pathology*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000473:pathology*
references.citation: Endocr Pract. 2011 Jul-Aug;17(4):636-46
references.pmid: 21846619
references.citation: Ophthalmology. 2006 Jul;113(7):1081-6
references.pmid: 16757028
references.citation: Ann Ophthalmol. 1986 Jul;18(7):233-5
references.pmid: 3752850
references.citation: Ophthalmology. 2002 Jun;109(6):1047-51
references.pmid: 12045042
references.citation: Ophthalmology. 2007 Nov;114(11):1965-72
references.pmid: 17628686
references.citation: Can J Physiol Pharmacol. 2003 Apr;81(4):371-84
references.pmid: 12769229
references.citation: J Endocrinol Invest. 2011 Feb;34(2):e30-5
references.pmid: 20651471
references.citation: Arch Ophthalmol. 2004 Apr;122(4):532-8
references.pmid: 15078671
references.citation: Am J Ophthalmol. 2007 Sep;144(3):461-2
references.pmid: 17765433
references.citation: Orbit. 2002 Jun;21(2):161-7
references.pmid: 12029573
references.citation: Arch Intern Med. 1974 Sep;134(3):415-7
references.pmid: 4855393
references.citation: Acta Ophthalmol (Copenh). 1980 Dec;58(6):971-4
references.pmid: 6277144
references.citation: Ger J Ophthalmol. 1995 Sep;4(5):264-8
references.pmid: 7496335
references.citation: Acta Ophthalmol (Copenh). 1979 Aug;57(4):530-42
references.pmid: 93390
references.citation: J Clin Endocrinol Metab. 1999 Feb;84(2):795-8
references.pmid: 10022455
references.citation: Ophthalmologica. 1979;179(3):168-72
references.pmid: 548853
references.citation: Surv Ophthalmol. 2000 Mar-Apr;44(5):367-408
references.pmid: 10734239
references.citation: Prog Clin Biol Res. 1988;266:103-16
references.pmid: 3380847
references.citation: J Pediatr Endocrinol Metab. 1998 Mar-Apr;11(2):261-5
references.pmid: 9642641
references.citation: Diabetologia. 1993 Apr;36(4):282-91
references.pmid: 7682976
references.citation: Acta Ophthalmol (Copenh). 1974;52(5):740-6
references.pmid: 4479566
references.citation: Brain Res Mol Brain Res. 1992 Jan;12(1-3):181-6
references.pmid: 1372066